Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
6.22
-0.09 (-1.43%)
At close: Jun 20, 2025, 4:00 PM
6.30
+0.08 (1.29%)
After-hours: Jun 20, 2025, 7:00 PM EDT

Emergent BioSolutions Statistics

Total Valuation

EBS has a market cap or net worth of $337.61 million. The enterprise value is $861.21 million.

Market Cap 337.61M
Enterprise Value 861.21M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, after market close.

Earnings Date Aug 5, 2025
Ex-Dividend Date n/a

Share Statistics

EBS has 54.28 million shares outstanding. The number of shares has increased by 3.58% in one year.

Current Share Class 54.28M
Shares Outstanding 54.28M
Shares Change (YoY) +3.58%
Shares Change (QoQ) +5.72%
Owned by Insiders (%) 2.73%
Owned by Institutions (%) 66.81%
Float 52.80M

Valuation Ratios

PE Ratio n/a
Forward PE 9.93
PS Ratio 0.35
Forward PS 0.58
PB Ratio 0.61
P/TBV Ratio 5.00
P/FCF Ratio 3.58
P/OCF Ratio 3.07
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.94, with an EV/FCF ratio of 9.12.

EV / Earnings n/a
EV / Sales 0.89
EV / EBITDA 13.94
EV / EBIT n/a
EV / FCF 9.12

Financial Position

The company has a current ratio of 6.32, with a Debt / Equity ratio of 1.22.

Current Ratio 6.32
Quick Ratio 3.15
Debt / Equity 1.22
Debt / EBITDA 10.89
Debt / FCF 7.13
Interest Coverage -0.68

Financial Efficiency

Return on equity (ROE) is -21.63% and return on invested capital (ROIC) is -1.85%.

Return on Equity (ROE) -21.63%
Return on Assets (ROA) -1.61%
Return on Invested Capital (ROIC) -1.85%
Return on Capital Employed (ROCE) -3.17%
Revenue Per Employee $1.07M
Profits Per Employee -$146,222
Employee Count 900
Asset Turnover 0.60
Inventory Turnover 1.89

Taxes

In the past 12 months, EBS has paid $69.30 million in taxes.

Income Tax 69.30M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.64% in the last 52 weeks. The beta is 2.11, so EBS's price volatility has been higher than the market average.

Beta (5Y) 2.11
52-Week Price Change +2.64%
50-Day Moving Average 5.75
200-Day Moving Average 7.72
Relative Strength Index (RSI) 49.86
Average Volume (20 Days) 985,030

Short Selling Information

The latest short interest is 7.83 million, so 14.43% of the outstanding shares have been sold short.

Short Interest 7.83M
Short Previous Month 7.75M
Short % of Shares Out 14.43%
Short % of Float 14.83%
Short Ratio (days to cover) 5.61

Income Statement

In the last 12 months, EBS had revenue of $965.40 million and -$131.60 million in losses. Loss per share was -$2.46.

Revenue 965.40M
Gross Profit 354.00M
Operating Income -41.60M
Pretax Income -578.10M
Net Income -131.60M
EBITDA 61.80M
EBIT -41.60M
Loss Per Share -$2.46
Full Income Statement

Balance Sheet

The company has $149.10 million in cash and $672.70 million in debt, giving a net cash position of -$523.60 million or -$9.65 per share.

Cash & Cash Equivalents 149.10M
Total Debt 672.70M
Net Cash -523.60M
Net Cash Per Share -$9.65
Equity (Book Value) 552.70M
Book Value Per Share 10.14
Working Capital 594.90M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $110.10 million and capital expenditures -$15.70 million, giving a free cash flow of $94.40 million.

Operating Cash Flow 110.10M
Capital Expenditures -15.70M
Free Cash Flow 94.40M
FCF Per Share $1.74
Full Cash Flow Statement

Margins

Gross margin is 36.67%, with operating and profit margins of -4.31% and -13.63%.

Gross Margin 36.67%
Operating Margin -4.31%
Pretax Margin -6.45%
Profit Margin -13.63%
EBITDA Margin 6.40%
EBIT Margin -4.31%
FCF Margin 9.78%

Dividends & Yields

EBS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.58%
Shareholder Yield -3.58%
Earnings Yield -38.98%
FCF Yield 27.96%
Dividend Details

Analyst Forecast

The average price target for EBS is $14.33, which is 130.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target $14.33
Price Target Difference 130.39%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 8.96%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

EBS has an Altman Z-Score of 1.22 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.22
Piotroski F-Score 4